Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endovascular Treatment Versus Optimal Medical Treatment of Atherosclerotic Renal Artery for Preserving Renal Function of the Ischemic Kidney.

NCT01208714 is registered in ClinicalTrials.gov with University Hospital Padova as lead sponsor.

NCT NCT01208714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01208714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endovascular Treatment Versus Optimal Medical Treatment of Atherosclerotic Renal Artery for Preserving Renal Function of the Ischemic Kidney.
Lead sponsor
University Hospital Padova
Phase
Phase 4
Overall status
Unknown status
Start date
December 31, 2010
Completion date
March 31, 2016
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal artery stenosis